Incannex Healthcare Inc. (NASDAQ:IXHL – Get Free Report)’s share price shot up 5.5% on Monday . The stock traded as high as $2.17 and last traded at $2.11. 30,861 shares were traded during mid-day trading, a decline of 72% from the average session volume of 111,707 shares. The stock had previously closed at $2.00.
Incannex Healthcare Stock Performance
The stock has a 50-day moving average of $2.05 and a two-hundred day moving average of $2.34. The company has a market cap of $133.94 million, a P/E ratio of -1.52 and a beta of 8.11.
Incannex Healthcare (NASDAQ:IXHL – Get Free Report) last issued its quarterly earnings results on Monday, September 30th. The company reported ($0.39) earnings per share for the quarter. The firm had revenue of $0.01 million during the quarter.
Institutional Trading of Incannex Healthcare
Incannex Healthcare Company Profile
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
Read More
- Five stocks we like better than Incannex Healthcare
- Industrial Products Stocks Investing
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What is the S&P 500 and How It is Distinct from Other Indexes
- Applied Materials Market Capitulates: Now is the Time to Buy
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
